Effects
| Use attributes for filter ! | |
| Initial release | USA |
|---|---|
| Directors | Dusty Nelson |
| Initial DVD release | USA |
| Producers | Pasquale Buba |
| John Harrison | |
| Cinematography | Toni Semple |
| Carl Augenstein | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2973750 |
About Effects
Crew members on the set of a horror film suspect that staged murders for the camera may be real.
Wegovy: Weight-loss drug firm becomes Europe's most valuable
... Wegovy and Ozempic - a diabetes treatment with similar Effects - have been described as " miracle" drugs...
Richard Hammond says daredevil stunts will still be seen on TV
... Asked if the incident had changed him, he told Today: " An acquired brain injury is a life-changing event and it has it has various Effects - long, short term...
UK cough syrup could be pharmacy-only over addiction fears
... But some people are also using it for its opioid Effects - to feed an addiction to pain-relieving medication - and the Medicines and Healthcare products Regulatory Agency (MHRA) says the rules around how people get hold of it should be tightened...
Teachers walk tightropes in face of no trans guidance
... A into gender-identity services in England says socially transitioning may have significant psychological Effects - and better information is needed about its outcomes...
Somali shock as Mogadishu mayor Madale filmed beating partygoers
... Some Somalis believe its long-term Effects - dramatic mood changes and depression amongst them - are destroying families and would like to see it banned...
China Covid: Five deaths under country's new counting method
... These calculations also take into account deaths which were not directly because of Covid but were caused by its knock-on Effects - including people being unable to access hospitals for the care they require...
Bernard Collaery: The spy case that ignited an Australian secrecy row
... Not all whistleblowers end up in court, but research shows most suffer other ill Effects - such as being bullied, demoted, fired, or even sued...
Whatever happened to the Novavax Covid vaccine?
... Both have been through formal clinical trials and found to be safe and effective by medicines regulators, while real-world monitoring over the past year suggests serious side Effects are extremely rare...
Wegovy: Weight-loss drug firm becomes Europe's most valuable
By Mariko OiBusiness reporter
The maker of weight-loss drug, Wegovy, has become Europe's most valuable firm dethroning the French luxury conglomerate LVMH.
Shares rose after the Danish pharmaceutical giant, Novo Nordisk , launched the popular drug in the UK.
At the close of trading on Monday, The Firm had a stock market valuation of $428bn (£339bn).
and also on the private market.
Wegovy is an obesity treatment that is taken once a week which tricks people into thinking that they are already full, so they end up eating less and losing weight.
Famous personalities such as, which has captivated Hollywood and The Public more widely since it was approved by regulators in the US in 2021.
Wegovy and Ozempic - a diabetes treatment with similar Effects - have been described as " miracle" drugs.
But experts warn the jabs are not a quick fix nor a substitute for a healthy diet and exercise.
In trials, users often put weight back on after stopping treatment.
There has been a global shortage of the jabs so only limited stock arrived for the UK's National Health System (NHS).
The Company said it would continue to restrict global supplies as it worked to ramp up manufacturing.
In the UK, say patients can only access Wegovy, which contains the drug semaglutide, if they are significantly overweight and have weight-related health problems.
According to the Organisation for Economic Co-operation and Development (OECD), nearly one in three adults are obese in the UK which is the highest level in Europe.
Last month, a New Trial showed Wegovy has also been proven to.
While the findings still have to be fully reviewed, experts agreed the results were potentially significant.
Related TopicsSource of news: bbc.com